在炎症性肠病中中性粒细胞:促进疾病与保护功能
Shaochen Yu1, Mengjie Zhang2, Wenlu Niu2
1Department of Emergency and Critical Care Medicine, Chuzhou Integrated Traditional Chinese and Western Medicine Hospital, Chuzhou, Anhui, China.
Frontiers in immunology
|February 2, 2026
概括
中性粒细胞在炎症性肠病 (IBD) 中起着双重作用. 它们既可以通过释放有害分子来促进疾病的进展,也可以通过清除碎片和促进组织修复来促进愈合.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 炎症性肠病 (IBD) 涉及遗传,环境,微生物和免疫因素的复杂相互作用.
- 中性粒细胞是早期免疫反应者,在IBD中透到炎症的肠粘膜.
- 它们在IBD病原发生中的作用是多方面的,需要进行详细的检查.
研究的目的:
- 系统地审查中性粒细胞在炎症性肠病 (IBD) 中的双重功能.
- 探索中性粒细胞异质性,可塑性和与肠道微生物群的相互作用.
- 提出针对IBD中中性粒细胞的新型精确治疗策略.
主要方法:
- 对IBD中中性粒细胞功能的现有文献进行系统审查.
- 对中性粒细胞衍生效应分子 (ROS,蛋白酶,NET) 的分析.
- 保护作用的研究,包括病原体清除和组织修复.
主要成果:
- 活性中性粒细胞通过效应分子促进IBD的发病/进展,破坏上皮屏障并促进炎症.
- 中性粒细胞还表现出保护功能,清除病原体/亡细胞并促进粘膜的愈合.
- 中性粒细胞的异质性和可塑性显著影响它们对IBD的影响.
结论:
- 中性粒细胞在IBD中充当"双重角色的守护者",具有有害和有益的影响.
- 了解中性粒细胞动态对于新的IBD治疗策略至关重要.
- 向中性粒细胞为IBD管理提供了精准医学方法的潜力.
更多相关视频
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
991
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
991
Inflammatory Bowel Disease V: Surgical Management
523
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
523
Inflammatory Bowel Disease IV: Pharmacological Management
610
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
610
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
742
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
742
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.5K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.5K


